MannKind Corp. (MNKD)
5.945
0.00 (0.00%)
USD |
NASDAQ |
Dec 15, 16:00
5.945
0.00 (0.00%)
After-Hours: 20:00
MannKind Research and Development Expense (Annual): 45.89M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.630B |
| Ocugen, Inc. | 30.16M |
| Protagonist Therapeutics, Inc. | 138.13M |
| Ovid Therapeutics, Inc. | 36.37M |
| Moderna, Inc. | 4.354B |